Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApq Global Regulatory News (APQ)

  • There is currently no data for APQ

Book Value Report

22 Mar 2024 07:00

RNS Number : 8528H
APQ Global Limited
22 March 2024
 

 

APQ Global Limited

("APQ Global" or the "Company")

 

Book value report

APQ Global is a company incorporated in Guernsey (company registration number 62008) which is listed on The International Stock Exchange and admitted to trading on AIM.

The Company hereby announces that as at the close of business on 29th February 2024, the unaudited book value per Ordinary Share was 30.20 US Dollar cents, equivalent to 23.87 Pounds Sterling pence.

The increase in book value reflects the unaudited third-party revaluation of the Company's private investments, notably a significant increase in the valuation of the Company's investment in Delphos International Ltd.

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation ("MAR") which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018; as amended. Upon publication of this announcement, the inside information is now considered to be in the public domain for the purposes of MAR.

- End -

Enquiries:

ir@apqglobal.com

IMPORTANT INFORMATION

Important Notice:

\* The term 'book value' herein includes the assets of APQ Global and its subsidiaries net of any liabilities. The figure in this announcement is an estimate and is based on unaudited estimated valuations in accordance with the Company's valuation policy as stated in the Company's AIM Admission Document. The Group has measured its private investments in accordance with IFRS 9 Financial Instruments. In September 2017, APQ Global Ltd issued 4,018 units of £5,000 nominal 3.5 per cent convertible unsecured loan stock 2024 ("CULS") to raise £20.09 million. In January 2018, APQ Global Ltd issued a further 1,982 CULS units at a price of £5,150 per £5,000 nominal to raise £10.21 million. Under IFRS, the CULS is a financial instrument and has been accounted for under IAS 32 Financial Instruments: Presentation and IFRS 9 (as effective for periods beginning on or after 1st January 2018). Therefore, the fair value of the CULS liability component has been calculated, with the difference between this and the fair value of the compound financial instrument as a whole being taken to equity. Following completion of the buy back and cancellation of CULS in April 2023, there are currently 5,920 units of CULS outstanding. Additionally, on January 28th, 2020, the Group issued 1,000,000 Warrants and 268,000 Convertible Preference Shares (CPS). In October 2021, the Group entered into an agreement to repurchase the entire amount of CPS and cancel all of the warrants outstanding. Under IFRS, the Warrants and the CPS were also Financial Instruments and were accounted for per the above guidance. This figure also includes the amounts awarded in accordance with the Company's Share-Based compensation scheme as adopted by the board on 19th April 2017 and accounted for in accordance with IFRS 2. Shares awarded under the scheme vest quarterly across 5 years. As of 29th February 2024, the total shares issued under the scheme amounted to 504,983.

Estimated results, performance or achievements may differ materially from any actual results, performance or achievements. No person has authority to give any representations or warranties (express or implied) as to, or in relation to, the accuracy, reliability or completeness of the information in this release, and all liability therefore is expressly disclaimed. Accordingly, none of the Company, the Corporate Services Provider or any of its/their respective members, directors, officers, agents, employees or advisers take any responsibility for, or will accept any liability whether direct or indirect, express or implied, contractual, tortious, statutory or otherwise, in respect of, the accuracy or completeness of the information or for any loss, howsoever arising, from the use of this release. Except as required by applicable law, the Company expressly disclaims any obligations to update or revise the above estimates to reflect any change in expectations, new information, subsequent events or otherwise.

 

 

Notes to Editors

APQ Global Limited

APQ Global (ticker: APQ LN) is an investment company incorporated in Guernsey. The Company focuses its investment activities globally (in Asia, Latin America, Eastern Europe, the Middle East, Africa and the Channel Islands, particularly).

The objective of the Company is to steadily grow its earnings to seek to deliver attractive returns and capital growth through a combination of building growing businesses as well as earning revenue from income generating operating activities in capital markets[1]. APQ Global run a well-diversified and liquid portfolio, take strategic stakes in selected businesses and plan to take operational control of companies through the acquisition of minority and majority stakes in companies with a focus on emerging markets.

1 Where we refer to revenue from income generating operating activities this relates to the revenue of our investee companies.

 


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQFLFLZXLXBBL
Date   Source Headline
8th Apr 20257:00 amRNSCancellation - APQ Global Limited
31st Mar 20252:30 pmRNSResult of EGM & CULS Holder Meeting
6th Mar 20251:30 pmRNSPublication of Circular & Notice of Meetings
6th Mar 202512:15 pmRNSResult of EGM
14th Feb 20254:00 pmRNSPublication of Circular & Notice of EGM
7th Feb 20257:00 amRNSCompany Update
23rd Dec 20243:16 pmRNSBook Value Report
16th Dec 20243:30 pmRNSResult of AGM
4th Dec 20244:30 pmRNSDirector/PDMR Shareholding
4th Dec 202411:16 amRNSHolding(s) in Company
2nd Dec 20247:30 amRNSRestoration - APQ Global Limited
29th Nov 20247:30 amRNSRestoration - APQ Global Limited
29th Nov 20247:25 amRNSRestoration to trading on AIM & ISM
29th Nov 20247:00 amRNSInterim Results
22nd Nov 202412:30 pmRNSNotice of AGM
15th Nov 20245:30 pmRNSFinal results for the year to 31 December 2023
30th Sep 20242:00 pmRNSResult of CULS Meeting
26th Sep 20249:30 amRNSProposed Increased Initial Payment to CULS Holders
24th Sep 20241:00 pmRNSRefinancing Update & Proposed CULS Holder Payment
16th Sep 20244:00 pmRNSUnaudited Final Results
9th Sep 20242:30 pmRNSBook Value Report
6th Sep 20245:15 pmRNSNotice of CULS Holder Meeting & Update
31st Jul 20247:00 amRNSPublication of Annual Report & Accounts
9th Jul 20243:00 pmRNSChange of Registered Office
1st Jul 20247:30 amRNSSuspension - APQ GLOBAL LIMITED
25th Jun 20244:00 pmRNSPublication of Annual Report & Accounts
13th Jun 20244:30 pmRNSChange of Registered Office
24th May 20247:00 amRNSBook Value Report
3rd Apr 20247:00 amRNSTrading Update
22nd Mar 20247:00 amRNSBook Value Report
6th Feb 20245:00 pmRNSBook Value Report
19th Dec 20235:00 pmRNSBook Value Report
20th Nov 20235:06 pmRNSBook Value Report
17th Oct 20235:00 pmRNSBook Value Report
27th Sep 202312:00 pmRNSBook Value Report
21st Sep 20231:00 pmRNSDirectorate Change
17th Aug 20235:00 pmRNSBook Value Report
9th Aug 20235:01 pmRNSResult of AGM
14th Jul 20231:00 pmRNSBook Value Report
10th Jul 202312:00 pmRNSNotice of AGM
22nd Jun 20231:00 pmRNSBook Value Report
6th Jun 20237:00 amRNSFinal results for the year to 31 December 2022
17th May 20231:00 pmRNSBook Value Report
20th Apr 202310:00 amRNSResult of Tender Offer for CULS
18th Apr 20237:00 amRNSBook Value Report
3rd Apr 20237:00 amRNSTender Offer for CULS
17th Mar 20237:00 amRNSBook Value Report
21st Feb 20239:00 amRNSBook Value Report
27th Jan 20237:00 amRNSBook Value Report
16th Dec 20225:00 pmRNSBook Value Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.